The Role of JAK/STAT Pathway in Fibrotic Diseases: Molecular and Cellular Mechanisms
Biomolecules · 06.01.2023 · 13 (1) · 119
DOI: 10.3390/biom13010119 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 06.01.2023. Verfasst von Jia Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610041, China. Hauptthemen laut MEDLINE: Janus Kinases, Neoplasms. Die Arbeit wurde bisher 167-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, West China Hospital of Sichuan University, Post-Doctor Research Project, West China Hospital.
Abstract (Originalsprache)
There are four members of the JAK family and seven of the STAT family in mammals. The JAK/STAT molecular pathway could be activated by broad hormones, cytokines, growth factors, and more. The JAK/STAT signaling pathway extensively mediates various biological processes such as cell proliferation, differentiation, migration, apoptosis, and immune regulation. JAK/STAT activation is closely related to growth and development, homeostasis, various solid tumors, inflammatory illness, and autoimmune diseases. Recently, with the deepening understanding of the JAK/STAT pathway, the relationship between JAK/STAT and the pathophysiology of fibrotic diseases was noticed, including the liver, renal, heart, bone marrow, and lung. JAK inhibitor has been approved for myelofibrosis, and subsequently, JAK/STAT may serve as a promising target for fibrosis in other organs. Therefore, this article reviews the roles and mechanisms of the JAK/STAT signaling pathway in fibrotic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
- Laboratory of Pulmonary Immunology and Inflammation, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China.
ORCID-Profile: Jia Liu, Faping Wang, Fengming Luo
Förderung
- National Natural Science Foundation of China
- West China Hospital of Sichuan University
- Post-Doctor Research Project, West China Hospital
Zitieren
APA
Liu, J., Wang, F., & Luo, F. (2023). The Role of JAK/STAT Pathway in Fibrotic Diseases: Molecular and Cellular Mechanisms. Biomolecules, 13(1), 119. https://doi.org/10.3390/biom13010119
Vancouver
Liu J, Wang F, Luo F. The Role of JAK/STAT Pathway in Fibrotic Diseases: Molecular and Cellular Mechanisms. Biomolecules. 2023;13(1):119. doi:10.3390/biom13010119
BibTeX
@article{Liu2023,
author = {Liu, Jia and Wang, Faping and Luo, Fengming},
title = {The Role of JAK/STAT Pathway in Fibrotic Diseases: Molecular and Cellular Mechanisms},
journal = {Biomolecules},
year = {2023},
volume = {13},
number = {1},
pages = {119},
doi = {10.3390/biom13010119}
}
EUVIMED